Importance Approximately half of newly-diagnosed hepatocellular carcinoma (HCC) cases
in the world occur in China, with hepatitis B virus (HBV) infection being the predominant risk …

Hepatocellular carcinoma is a leading cancer worldwide. Its incidence is increasing, and is
closely related to advanced liver disease. Cirrhosis represents the greatest risk factor for this …

This guidance provides a data-supported approach to the diagnosis, staging, and treatment
of patients diagnosed with hepatocellular carcinoma (HCC). A guidance document is …

EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …

Background & Aims We aimed to develop a prognostic classification scheme with treatment
guidance for Asian patients with hepatocellular carcinoma (HCC). Methods We collected …

Primary liver cancer, mostly hepatocellular carcinoma, remains a difficult-to-treat cancer.
Incidence of liver cancer varies geographically and parallels with the geographic prevalence …

EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …

The intermediate stage of hepatocellular carcinoma (HCC) comprises a highly
heterogeneous patient population and therefore poses unique challenges for therapeutic …

Hepatocellular carcinoma (HCC) is one of the fastest‐rising causes of cancer‐related death
worldwide, but its deficiency of specific biomarkers and therapeutic targets in the early …

Objective: The efficacy and safety of hepatic resection (HR) to treat patients with Barcelona
Clinic Liver Cancer (BCLC) stage B and C hepatocellular carcinoma (HCC) was …